Marc Feldmann's most recent trade in 180 Life Sciences Corp was a trade of 135,377 Common Stock done . Disclosure was reported to the exchange on Dec. 28, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
180 Life Sciences Corp | Marc Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 135,377 | 250,874 | - | 0 | Common Stock | |
180 Life Sciences Corp | Marc Feldmann | Director | Sale of securities on an exchange or to another person at price $ 0.19 per share. | 15 Dec 2023 | 25,000 | 115,497 | - | 0.2 | 4,700 | Common Stock |
180 Life Sciences Corp | Marc Feldmann | Director | Purchase of securities on an exchange or from another person at price $ 4.07 per share. | 08 Dec 2021 | 50,000 | 2,809,930 | - | 4.1 | 203,500 | Common Stock |
180 Life Sciences Corp | Marc Feldmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
180 Life Sciences Corp | Marc Feldmann | Director | Grant, award, or other acquisition of securities at price $ 3.95 per share. | 08 Dec 2021 | 5,536 | 2,759,930 | - | 3.9 | 21,867 | Common Stock |
180 Life Sciences Corp | Marc Feldmann | Director | Grant, award, or other acquisition of securities at price $ 6.00 per share. | 30 Sep 2021 | 136,636 | 2,754,394 | - | 6 | 819,816 | Common Stock |
180 Life Sciences Corp | Marc Feldmann | Director | Grant, award, or other acquisition of securities at price $ 6.14 per share. | 07 Apr 2021 | 20,910 | 2,617,758 | - | 6.1 | 128,387 | Common Stock |